Brokerages Set Incyte Corporation (NASDAQ:INCY) Price Target at $103.94

Analysts maintain a 'Hold' rating on the biopharmaceutical company's stock.

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

Incyte Corporation (NASDAQ:INCY) has received an average recommendation of 'Hold' from the 21 analysts covering the stock, with one sell, 11 hold, and 9 buy ratings. The average 12-month price target among brokerages is $104.00.

Why it matters

Incyte is a prominent biopharmaceutical company focused on developing novel therapies for oncology and inflammation. The analyst ratings and price targets provide insight into how Wall Street views the company's prospects and valuation.

The details

Several equity analysts have weighed in on Incyte's stock. Weiss Ratings maintained a 'hold (c+)' rating, while The Goldman Sachs Group reiterated a 'neutral' rating and $90.00 target price. TD Cowen kept a 'buy' rating, and Mizuho set a $121.00 price target and 'outperform' rating. Royal Bank of Canada lowered its price objective from $95.00 to $92.00 and kept a 'sector perform' rating.

  • Incyte reported its latest quarterly earnings on February 10, 2026.

The players

Incyte Corporation

A Wilmington, Delaware-based biopharmaceutical company focused on discovering, developing, and commercializing novel therapies in oncology and inflammation.

Weiss Ratings

A research firm that provides ratings and analysis on stocks, mutual funds, and other financial products.

The Goldman Sachs Group

A multinational investment bank and financial services company.

TD Cowen

An investment bank and financial services firm.

Mizuho

A Japanese banking and financial services group.

Royal Bank of Canada

A multinational financial services company headquartered in Canada.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee (Instagram)

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.